NO974117L - Nye aminoalkanfosfinsyrer og deres salter - Google Patents
Nye aminoalkanfosfinsyrer og deres salterInfo
- Publication number
- NO974117L NO974117L NO974117A NO974117A NO974117L NO 974117 L NO974117 L NO 974117L NO 974117 A NO974117 A NO 974117A NO 974117 A NO974117 A NO 974117A NO 974117 L NO974117 L NO 974117L
- Authority
- NO
- Norway
- Prior art keywords
- ethyl
- dichlorophenyl
- salts
- dimethoxyphenyl
- prop
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- -1 α-cyclopropyl-3,4-dichloro-benzyl-trimethoxybenzyl Chemical group 0.000 abstract 17
- 239000005557 antagonist Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 abstract 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000068 chlorophenyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Air Bags (AREA)
Abstract
Forbindelse med formel I ^,- 0 R, R, HO,.ll f i' (I) hvor R står for benzyl, R^ står for hydroksy, R2 står for a-cyklopropyl-3,4-dlklor-benzyl-trlmetoksybenzyl, l-(3,5-dlmetoksyfenyl )etyl, l-(3 ,4-dlklorfenyl)etyl, 2- (3,4-dlklorfenyl)etyl, l-(3-klor-4-Jod-fenyl)etyl, 2- (3,4-dl kl orfenyl)-2-hydroksy-etyl, 2-(3,4-dlklorfenyl)- 2-hydroksy-etyl, l-(2 ,4-dlmetoksyfenyl)etyl, l-(2,5- dlmetoksyfenyl)etyl, l-(2,6-dlmetoksyfenyl)etyl, 1- (3,4-dlmetoksyfenyl)etyl, l-(3 ,4-metylend loksyfenyl)- etyl, l-(3,4,5-trlmetoksyfenyl)etyl, 3-fenylprop-2-yl, 3-fenyl-3-hydroksy-prop-2-yl, 1-, 2- eller 3-(3,4- dlklorfenyl)propyl , 3-(3,4-dlklorfenyl)prop-2-yl , 3- (3,4-dlklorfenyl)-3-hydroksy-prop-2-yl eller 4-(3,4- dlklorfenyl )butyl og R3 står for hydrogen, eller R står for 4-klorbenzyl, 4-metylbenzyl, 4-metoksybenzyl eller cykloheks-3-enylmetyl og R]^, R2 og R3 står for hydrogen, og deres salter har GABAg-antagonistlske egenskaper og kan bil anvendt for behandling av sykdommer som blir påvirket av GABAg-antagonister.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH340491 | 1991-11-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO974117L true NO974117L (no) | 1993-05-24 |
| NO974117D0 NO974117D0 (no) | 1997-09-08 |
Family
ID=4255259
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92924479A NO924479L (no) | 1991-11-21 | 1992-11-20 | Nye aminoalkanfosfinsyrer og deres salter |
| NO974116A NO974116D0 (no) | 1991-11-21 | 1997-09-08 | Nye aminoalkanfosfinsyrer og deres salter |
| NO974115A NO974115D0 (no) | 1991-11-21 | 1997-09-08 | Nye aminoalkanfosfinsyrer og deres salter |
| NO974117A NO974117D0 (no) | 1991-11-21 | 1997-09-08 | Nye aminoalkanfosfinsyrer og deres salter |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92924479A NO924479L (no) | 1991-11-21 | 1992-11-20 | Nye aminoalkanfosfinsyrer og deres salter |
| NO974116A NO974116D0 (no) | 1991-11-21 | 1997-09-08 | Nye aminoalkanfosfinsyrer og deres salter |
| NO974115A NO974115D0 (no) | 1991-11-21 | 1997-09-08 | Nye aminoalkanfosfinsyrer og deres salter |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5376684A (no) |
| EP (2) | EP0767174A1 (no) |
| JP (1) | JPH05247069A (no) |
| KR (1) | KR930010047A (no) |
| AU (2) | AU662938B2 (no) |
| CA (1) | CA2083307A1 (no) |
| FI (1) | FI925243A (no) |
| IL (1) | IL103808A0 (no) |
| MX (1) | MX9206702A (no) |
| NO (4) | NO924479L (no) |
| NZ (1) | NZ245185A (no) |
| PH (1) | PH30097A (no) |
| TW (1) | TW213466B (no) |
| ZA (1) | ZA928979B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL114631A (en) * | 1990-06-22 | 1998-12-06 | Novartis Ag | Anti-epileptic preparations containing antagonists of BABAG |
| EP0767174A1 (de) * | 1991-11-21 | 1997-04-09 | Ciba-Geigy Ag | Neue Aminoalkanphosphinsäuren und ihre Salze |
| AU662404B2 (en) * | 1992-05-08 | 1995-08-31 | Novartis Ag | Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids |
| WO1997011953A1 (en) * | 1995-09-28 | 1997-04-03 | Novartis Ag | Novel hydroxylated and alkoxylated n- and/or p-aralkylphosphinic acid derivatives |
| DE69827635T2 (de) * | 1997-06-23 | 2006-02-02 | Neuro Therapeutics Ltd., Toorak | Gaba-c-rezeptor-antagonisten zur stimulation des erinnerungsvermögens |
| DE10014127A1 (de) * | 2000-03-22 | 2001-10-18 | Hassan Jomaa | Verwendung von phosphororganischen Verbindungen zur Behandlung von Infektionen |
| US6462084B1 (en) | 2001-05-14 | 2002-10-08 | Brookhaven Science Associates, Llc | Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
| AR045794A1 (es) * | 2003-09-23 | 2005-11-16 | Aventis Pharma Inc | Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico |
| GB0327186D0 (en) * | 2003-11-21 | 2003-12-24 | Novartis Ag | Organic compounds |
| US7566738B2 (en) * | 2004-11-03 | 2009-07-28 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
| US7494985B2 (en) * | 2004-11-03 | 2009-02-24 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| AR052669A1 (es) * | 2005-02-11 | 2007-03-28 | Aventis Pharma Inc | Esteres de acido de acido propano - fosfinico sustituido; composiciones farmaceuticas que los contienen y su uso para el tratamiento de trastornos psiquiatricos. |
| WO2008033572A1 (en) * | 2006-09-15 | 2008-03-20 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2440239A1 (de) * | 1974-08-22 | 1976-03-04 | Hoechst Ag | Innere ammoniumsalze von phosphinsaeuren |
| EP0093081B1 (de) * | 1982-04-23 | 1986-03-19 | Ciba-Geigy Ag | Herbizide und pflanzenwuchsregulierende Mittel |
| US4536355A (en) * | 1982-10-08 | 1985-08-20 | Zoecon Corporation | Phenoxyphenylaminoalkylphosphinates useful in weed control |
| US5243062A (en) * | 1984-10-12 | 1993-09-07 | Ciba-Geigy Corporation | Substituted propane-phosphonous acid compounds |
| GB8425872D0 (en) * | 1984-10-12 | 1984-11-21 | Ciba Geigy Ag | Chemical compounds |
| DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
| US5300679A (en) * | 1987-12-04 | 1994-04-05 | Ciba-Geigy Corporation | Substituted propane-phosphinic acid compounds |
| US5190933A (en) * | 1987-12-04 | 1993-03-02 | Ciba-Geigy Corporation | Substituted propane-phosphinic acid compounds |
| GB8728483D0 (en) * | 1987-12-04 | 1988-01-13 | Ciba Geigy Ag | Chemical compounds |
| DK270488D0 (da) * | 1988-05-18 | 1988-05-18 | Novo Industri As | Hidtil ukendte o-substituerede ketoximer |
| GB8820266D0 (en) * | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| US5281747A (en) * | 1989-05-13 | 1994-01-25 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| GB8911017D0 (en) * | 1989-05-13 | 1989-06-28 | Ciba Geigy Ag | Substituted aminoalkylphosphinic acids |
| GB8912814D0 (en) * | 1989-06-03 | 1989-07-19 | Ciba Geigy Ag | P-substituted propane-phospinic acid compounds |
| US5190934A (en) * | 1989-06-03 | 1993-03-02 | Ciba-Geigy Corporation | P-subsituted propane-phosphinic acid compounds |
| IL114631A (en) * | 1990-06-22 | 1998-12-06 | Novartis Ag | Anti-epileptic preparations containing antagonists of BABAG |
| EP0767174A1 (de) * | 1991-11-21 | 1997-04-09 | Ciba-Geigy Ag | Neue Aminoalkanphosphinsäuren und ihre Salze |
| AU662404B2 (en) * | 1992-05-08 | 1995-08-31 | Novartis Ag | Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids |
-
1992
- 1992-11-12 EP EP96118735A patent/EP0767174A1/de not_active Withdrawn
- 1992-11-12 EP EP19920810879 patent/EP0543780A3/de not_active Ceased
- 1992-11-18 FI FI925243A patent/FI925243A/fi not_active Application Discontinuation
- 1992-11-19 IL IL103808A patent/IL103808A0/xx unknown
- 1992-11-19 CA CA002083307A patent/CA2083307A1/en not_active Abandoned
- 1992-11-19 US US07/979,513 patent/US5376684A/en not_active Expired - Fee Related
- 1992-11-19 JP JP4310082A patent/JPH05247069A/ja active Pending
- 1992-11-19 NZ NZ245185A patent/NZ245185A/en unknown
- 1992-11-19 TW TW081109255A patent/TW213466B/zh active
- 1992-11-19 MX MX9206702A patent/MX9206702A/es not_active Application Discontinuation
- 1992-11-19 AU AU28504/92A patent/AU662938B2/en not_active Ceased
- 1992-11-20 PH PH45301A patent/PH30097A/en unknown
- 1992-11-20 ZA ZA928979A patent/ZA928979B/xx unknown
- 1992-11-20 NO NO92924479A patent/NO924479L/no unknown
- 1992-11-21 KR KR1019920021950A patent/KR930010047A/ko not_active Application Discontinuation
-
1994
- 1994-09-16 US US08/308,040 patent/US5500418A/en not_active Expired - Fee Related
-
1995
- 1995-12-14 AU AU40456/95A patent/AU4045695A/en not_active Abandoned
-
1997
- 1997-09-08 NO NO974116A patent/NO974116D0/no unknown
- 1997-09-08 NO NO974115A patent/NO974115D0/no unknown
- 1997-09-08 NO NO974117A patent/NO974117D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2083307A1 (en) | 1993-05-22 |
| AU662938B2 (en) | 1995-09-21 |
| US5376684A (en) | 1994-12-27 |
| PH30097A (en) | 1996-12-27 |
| FI925243A (fi) | 1993-05-22 |
| MX9206702A (es) | 1994-06-30 |
| TW213466B (no) | 1993-09-21 |
| NO974116D0 (no) | 1997-09-08 |
| KR930010047A (ko) | 1993-06-21 |
| NZ245185A (en) | 1995-04-27 |
| ZA928979B (en) | 1994-04-15 |
| NO974115L (no) | 1993-05-24 |
| NO924479D0 (no) | 1992-11-20 |
| JPH05247069A (ja) | 1993-09-24 |
| US5500418A (en) | 1996-03-19 |
| NO974115D0 (no) | 1997-09-08 |
| AU4045695A (en) | 1996-04-26 |
| EP0767174A1 (de) | 1997-04-09 |
| NO974116L (no) | 1993-05-24 |
| FI925243A0 (fi) | 1992-11-18 |
| NO924479L (no) | 1993-05-24 |
| NO974117D0 (no) | 1997-09-08 |
| EP0543780A3 (en) | 1993-09-01 |
| EP0543780A2 (de) | 1993-05-26 |
| IL103808A0 (en) | 1993-04-04 |
| AU2850492A (en) | 1993-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO974117L (no) | Nye aminoalkanfosfinsyrer og deres salter | |
| FI943948A0 (fi) | Heterosykliset hiilihappojohdannaiset | |
| NO986055D0 (no) | Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat | |
| WO2000047554A3 (en) | INHIBITORS OF FACTOR Xa | |
| RS53252B (en) | PIPERAZINE WITH OR-SUBSTITUTED PHENYL GROUP AND THEIR USE AS GLYT1 INHIBITOR | |
| ATE425964T1 (de) | Cyclische amidinderivate | |
| NO20006482L (no) | 4-benzyl piperidinalkylsulfoksy-heterocykler og deres anvendelse som subtype-selektive NMDA reseptorantagonister | |
| ATE398128T1 (de) | Neue purinderivate, deren herstelllung und deren verwendung als arzneimittel | |
| ATE238280T1 (de) | Verwendung eines pharmazeutisch geeigneten salzes von (3r,2'r)-3-((cyclopentyl- hydroxyphenylacetyl)oxy)-1,1-dimethyl- pyrrolidinium zur herstellung eines arzneimittels | |
| ATE327225T1 (de) | Neue verwendung von benzothiazolderivaten | |
| NO20065327L (no) | Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid. | |
| NO991761L (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| CA2124680A1 (en) | Piperazine derivatives as 5-ht1a antagonists | |
| ATE147071T1 (de) | 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung | |
| DK0738269T5 (da) | Piperidinderivater med PAF-antagonistaktivitet | |
| NZ595910A (en) | Carbinol compound having heterocyclic linker | |
| NO20023001L (no) | Substituerte piperazinderivater som MTP inhibitorer | |
| KR880000410A (ko) | 이치환된 피페라진 | |
| YU46592B (sh) | Postupak za dobijanje ž-acil-3-/4-(2-pirimidinil)-1-piperazinil/propana | |
| ATE155128T1 (de) | Buttersäurederivate, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfung | |
| US4029790A (en) | 1-Benzoyl-2 or 4 [2-(4-phenyl-piperazino)-ethyl]-piperidines | |
| ATE455769T1 (de) | Substituierte thiazole und ihre verwendung zur herstellung von arzneimitteln | |
| DK1245564T3 (da) | Benzamidinderivater | |
| ATE92058T1 (de) | Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alphaaryl-(alpha-alkyl)-methoxy)-butyl)-1-piperaziny > mit serotoninergischer wirkung. | |
| NO950731L (no) | Optisk aktive karboksamidderivater |